531458 BOSTONBIO

Boston Bio Systems Share Price

 

 

Start SIP in BOSTONBIO

Start SIP

Performance

  • Low
  • ₹8
  • High
  • ₹8
  • 52 Week Low
  • ₹6
  • 52 Week High
  • ₹22
  • Open Price₹8
  • Previous Close₹8
  • Volume102

Investment Returns

  • Over 1 Month + 9.73%
  • Over 3 Month -5.21%
  • Over 6 Month + 6.66%
  • Over 1 Year -52.21%

Smart Investing Starts Here Start SIP with Boston Bio Systems for Steady Growth!

Invest Now

Boston Bio Systems Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -
  • PEG Ratio
  • -
  • Market Cap Cr
  • 6
  • P/B Ratio
  • 0.9
  • Average True Range
  • 0.22
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.12
  • RSI
  • 69.61
  • MFI
  • 78.49

Boston Bio Systems Financials

Boston Bio Systems Technicals

EMA & SMA

Current Price
₹8.01
+ 0.38 (4.98%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 14
  • 20 Day
  • ₹7.13
  • 50 Day
  • ₹7.33
  • 100 Day
  • ₹7.70
  • 200 Day
  • -

Resistance and Support

7.88 Pivot Speed
  • R3 8.52
  • R2 8.26
  • R1 8.14
  • S1 7.76
  • S2 7.50
  • S3 7.38

Boston Bio Systems Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-14 Quarterly Results
2025-08-14 Quarterly Results
2025-05-30 Audited Results

Boston Bio Systems F&O

Boston Bio Systems Shareholding Pattern

2.14%
85.22%
12.64%

About Boston Bio Systems

  • NSE Symbol
  • BOSTONBIO
  • BSE Symbol
  • 531458
  • Managing Director
  • Mr. Ghanshyam Dhananjay Gavali
  • ISIN
  • INE109B01019

Similar Stocks to Boston Bio Systems

Boston Bio Systems FAQs

Boston Bio Systems share price is ₹8 As on 03 January, 2026 | 05:11

The Market Cap of Boston Bio Systems is ₹5.6 Cr As on 03 January, 2026 | 05:11

The P/E ratio of Boston Bio Systems is As on 03 January, 2026 | 05:11

The PB ratio of Boston Bio Systems is 0.9 As on 03 January, 2026 | 05:11

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23